<!DOCTYPE HTML>
<html>
	<head>
<style>
.badge-container {
  display: inline-block;
  vertical-align: middle;
  margin-left: 10px;
}
.badge-container > span {
  display: inline-block;
  margin-right: 5px;
}
</style>
<style>
.badge-container {
  display: inline-block;
  vertical-align: middle;
  margin-left: 10px;
}
.badge-container > span {
  display: inline-block;
  margin-right: 5px;
}
</style> 
		<title>Xingyu Chen - Cancer Genomics @ JHU</title>
		<meta charset="utf-8" />
		<meta name="viewport" content="width=device-width, initial-scale=1, user-scalable=no" />
		<link rel="stylesheet" href="assets/css/main.css" />
		<link rel="icon" href="images/web-icon_avatar.png">
	</head>
	<body class="is-preload">

		<!-- Header -->
			<section id="header">
				<header>
					<span class="image avatar"><img src="images/avatar.png" alt="" /></span>
					<h1 id="logo"><a href="#">Xingyu Chen</a></h1>
					<p>Baltimore, MD <br />
					<a href="https://scholar.google.com/citations?user=Vj8vClIAAAAJ&hl=en&oi=ao" target="_blank">Google Scholar</a> <br />
					<a href="https://orcid.org/0000-0002-9284-4950" target="_blank">ORCID</a></p>
				</header>
				<nav id="nav">
					<ul>
						<li><a href="#about" class="active">About</a></li>
						<li><a href="#Research Projects">Research Projects</a></li>
						<li><a href="#research">Research Experience</a></li>
						<li><a href="#cv">Academic CV</a></li>
						<li><a href="#contact">Contact</a></li>
					</ul>
				</nav>
				<footer>
					<ul class="icons">
						<li><a href="https://x.com/Xingyu_Chen_" class="icon brands fa-twitter" target="_blank"><span class="label">Twitter</span></a></li>

						<li><a id="mlink" href="#" class="icon solid fa-envelope"><span class="label">Email</span></a></li>
						<li><a href="https://orcid.org/0000-0002-9284-4950" target="_blank"><img src="images/orcid.png" alt="ORCID" style="width: 24px; height: 24px; vertical-align: middle;"/></a></li>
					</ul>
				</footer>
			</section>

		<!-- Wrapper -->
			<div id="wrapper">

				<!-- Main -->
					<div id="main">

						<!-- About -->
							<section id="about">
							<!-- About -->
<section id="about">
  <!-- 改成 image fit（整图等比） -->
  <span class="image fit">
    <img src="images/Picture1.png" alt="Picture1">
  </span>


								<div class="container">
									<header class="major">
										<h3>About Me</h3>
									</header>
									<p>I am a first-year PhD student in Cell, Molecular & Developmental Biology at Johns Hopkins University, specialising in urologic surgery and computational bioinformatics. My research integrates single-cell and spatial multi-omics with advanced machine-learning to dissect tumour heterogeneity and immune evasion in bladder and prostate cancers, uncovering actionable vulnerabilities for first-in-class precision therapies.</p>
									
									<p>Trained in China, I earned an MD-equivalent degree and an MSc in Oncology focused on urologic malignancies. I subsequently spent three years as a research bioinformatician in the Department of Urology at Cedars-Sinai Medical Center, where I conducted NIH-funded projects under my PI’s direction and mentored junior scientists, including a bioinformatician with a master’s degree from Columbia University and a visiting MD student from Tsinghua University.</p>
									
									<p>I have authored more than 20 peer-reviewed papers, including two in <i>Nature</i> —one as co-first author (2023) and one as sole first author (2025). Our Y-chromosome study appeared on Nature’s cover and was highlighted by both the National Cancer Institute and the NIH. I also hold several U.S. patents, review manuscripts for more than 40 SCI-indexed journals, serve on multiple early-career editorial boards, and co-lead the “Tumorigenesis” WG sessions for the Prostate Cancer Foundation’s Young Investigator.</p>

									<p>My long-term ambition is to practise as a physician-scientist who harnesses computation, single-cell biology, and artificial intelligence to revolutionise cancer detection, prognostication, and treatment.</p>
									

									<h4>Research Interests</h4>
									<ul>
										<li>Cancer Immunotherapy & Tumor Microenvironment</li>
										<li>Bioinformatics and Computational Biology</li>
										<li>Multi-Omics Integration & Predictive Modeling & Radiogenomics</li>
										<li>Single-Cell & Spatial Transcriptomics</li>
										<li>Large Language Models in Genomics</li>
									</ul>
								</div>
							</section>



						<!-- Publications -->
							<section id="publications">
								<div class="container">
									<header class="major">
										<h2>Research Projects</h2>
									</header>

									
									<h4> (1) The Role of Y‑Chromosome Loss in Immune Modulation and Tumorigenesis</h4>
									<img src="images/Selected Publications.png" class="img-fluid" alt="Selected Publications">
									<div class="features">
										<article>
											<div class="image-container">
												<h5>Concurrent loss of the Y chromosome in cancer and T cells impacts outcome</h5>
												<p><strong>Chen, X</strong>., Shen, Y., Choi, S. et al. Nature 642, 1041–1050 (2025). <strong>First author</strong>.  
									<a href="https://doi.org/10.1038/s41586-025-09071-2" target="_blank">https://doi.org/10.1038/s41586-025-09071-2</a>
									<span class="badge-container"> 
									  <span class="__dimensions_badge_embed__" data-doi="10.1038/s41586-025-09071-2" data-style="small_circle"></span> 
									  <span class="altmetric-embed" data-doi="10.1038/s41586-025-09071-2" data-badge-type="donut"></span> 
									</span> 
								 </p>
												<p><div class="left-align-text">In our 2025 Nature study (first authored by me), we demonstrated that age-related loss of the Y chromosome (LOY)—which affects up to 40% of elderly men—occurs not only in tumour cells but also spreads to infiltrating T cells; this "double-LOY" condition cripples anti-tumour immunity and predicts the worst survival across 4,000 male cancer samples and more than one million single-cell profiles. Mechanistically, losing key Y-linked genes (KDM5D, UTY, DDX3Y) weakens tumour antigen presentation, while LOY T cells become exhausted (↓ GZMB/PRF1, ↑ PD-1/CTLA-4), offering an explanation for men's higher cancer burden. These findings argue for routine LOY testing in male-predominant cancers, careful exclusion of LOY T cells from cell therapies, and development of treatments that restore or block LOY-driven immune collapse.</div></p>
									<img src="images/nature12.png" class="img-fluid" alt="nature12">
											</div>
										</article>
										<article>
											<div class="image-container">
								<h5>Y chromosome loss in cancer drives growth by evasion of adaptive immunity</h5>
								<p>Abdel-Hafiz, H.A., Schafer, J.M., <strong>Chen, X</strong>. et al. Nature 619, 624-631 (2023). <strong>Co-first author</strong>.  
									<a href="https://doi.org/10.1038/s41586-023-06234-x" target="_blank">https://doi.org/10.1038/s41586-023-06234-x</a>
									<span class="badge-container"> 
									  <span class="__dimensions_badge_embed__" data-doi="10.1038/s41586-023-06234-x" data-style="small_circle"></span> 
									  <span class="altmetric-embed" data-doi="10.1038/s41586-023-06234-x" data-badge-type="donut"></span> 
									</span> 
								 </p>
								<p><div class="left-align-text">Our 2023 Nature paper (co-first authored by me) delivered the first direct evidence that loss of the Y chromosome (LOY) in cancer cells reshapes anti-tumor immunity. Using mouse models and large human cohorts of bladder cancer, we showed that Y-negative tumors up-regulate PD-L1, drive T-cell exhaustion, and proliferate twice as fast as Y-positive tumors. Paradoxically, the same immune-evasive state renders LOY tumors markedly more responsive to immune-checkpoint blockade (e.g., atezolizumab). These findings uncover a causal link between sex-chromosome loss and immune escape, offer a mechanistic explanation for the higher incidence and poorer prognosis of many cancers in men, and position LOY as a predictive biomarker for immunotherapy benefit.</div></p>
								</div>
										</article>
									</div>
									
									
<h4> (2) Multi-Omics Biomarker Toolkit Driving Precision Oncology in Urologic Cancers</h4>
									<p><div class="left-align-text">My biomarker work spans several studies that converge on three advances: (1) AI-powered radiogenomics that pairs MRI with RNA-seq to stage muscle-invasive bladder cancer more accurately than imaging alone; (2) multi-omics immune signatures—covering pyroptosis, hypoxia, autophagy, ferroptosis, m6A and CD8-T-effector checkpoints—that stratify patients and predict checkpoint-inhibitor benefit across bladder, ovarian and other cancers; and (3) mechanistic discoveries (e.g., KDM5D/UTY loss, SRSF10-CDC25A splicing, lncRNA FOXD1-AS1) that reveal druggable pathways driving tumour metabolism and immune escape, together forming a toolkit for precision oncology.</div></p>
									<ol>
										<li>Qureshi TA*, <strong style="font-weight: 900;">Chen X*</strong>, Xie Y, Murakami K, Sakatani T, Kita Y, Kobayashi T, Miyake M, Knott SRV, Li D et al: MRI/RNA-Seq-Based Radiogenomics and Artificial Intelligence for More Accurate Staging of Muscle-Invasive Bladder Cancer. Int J Mol Sci 2023, 25(1). <strong style="font-weight: 900;">(Co-first Author)</strong><br></li>
						<li><strong style="font-weight: 900;">Chen X</strong>, Xu R, He D, Zhang Y, Chen H, Zhu Y, Cheng Y, Liu R, Zhu R, Gong L et al: CD8(+) T effector and immune checkpoint signatures predict prognosis and responsiveness to immunotherapy in bladder cancer. Oncogene 2021, 40(43):6223-6234. <strong style="font-weight: 900;">(First Author)</strong><br></li>
						<li><strong style="font-weight: 900;">Chen X*</strong>, Chen H*, Yao H, Zhao K, Zhang Y, He D, Zhu Y, Cheng Y, Liu R, Zhu R, Gong L et al: Turning up the heat on non-immunoreactive tumors: pyroptosis influences the tumor immune microenvironment in bladder cancer. Oncogene 2021, 40(45):6381-6393. <strong style="font-weight: 900;">(Co-first Author)</strong><br></li>
						<li><strong style="font-weight: 900;">Chen X*</strong>, Lan H*, He D, Zhu Y, Xiao M, Lan H, Wang Z, Cao K: Analysis of Tumor Microenvironment Characteristics in Bladder Cancer: Implications for Immune Checkpoint Inhibitor Therapy. Front Immunol 2021, 12:672158. <strong style="font-weight: 900;">(Co-first Author)</strong><br></li>
						<li><strong style="font-weight: 900;">Chen X*</strong>, Lan H*, He D, Xu R, Zhang Y, Cheng Y, Chen H, Xiao S, Cao K: Multi-Omics Profiling Identifies Risk Hypoxia-Related Signatures for Ovarian Cancer Prognosis. Front Immunol 2021, 12:645839. <strong style="font-weight: 900;">(Co-first Author)</strong><br></li>
						<li><strong style="font-weight: 900;">Chen X*</strong>, Lan H*, He D, Wang Z, Xu R, Yuan J, Xiao M, Zhang Y, Gong L, Xiao S et al: Analysis of Autophagy-Related Signatures Identified Two Distinct Subtypes for Evaluating the Tumor Immune Microenvironment and Predicting Prognosis in Ovarian Cancer. Front Oncol 2021, 11:616133. <strong style="font-weight: 900;">(Co-first Author)</strong><br></li>
						<li><strong>Chen X</strong>, Jin Y, Gong L, He D, Cheng Y, Xiao M, Zhu Y, Wang Z, Cao K: Bioinformatics Analysis Finds Immune Gene Markers Related to the Prognosis of Bladder Cancer. Front Genet 2020, 11:607. <strong style="font-weight: 900;">(First Author)</strong><br></li>
						<li>Deng H, Tang F, Zhou M, Shan D, <strong style="font-weight: 900;">Chen X*</strong>, Cao K*: Identification and Validation of N6-Methyladenosine-Related Biomarkers for Bladder Cancer: Implications for Immunotherapy. Front Oncol 2022, 12:820242. <strong style="font-weight: 900;">(Co-corresponding Author)</strong><br></li>
									</ol>
									<p>*These authors contributed equally</p>
								</div>
							</section>

						<!-- Research Experience -->
							<section id="research">
								<div class="container">
									<header class="major">
										<h2>Research Experience</h2>
									</header>

									<!-- Research Rotations Snippet (with extra gap between bullet and text) -->

<!-- Research Experience Section (inherits global font sizes) -->
<style>
  /* Headings */
  .experience-title {
    margin: 2rem 0 0.6rem 0;
    font-family: "Inter", sans-serif;
    font-weight: 600; /* keep weight, let theme decide size */
  }

  /* Lists */
  .experience-list {
    margin: 0 0 1rem 1.5rem;   /* left indent */
    padding-left: 0.5rem;       /* gap between bullet and text */
    list-style: disc outside;
    line-height: 1.6;           /* readable line height */
  }

  .experience-list li {
    margin-bottom: 0.4rem;      /* vertical spacing */
    padding-left: 0.25rem;      /* extra gap bullet → text */
  }

  .experience-list strong {
    color: var(--accent-color, #0052cc);
  }
</style>

<div class="experience-section">
  <!-- Rotations -->
  <h4 class="experience-title">Research Rotations — Johns Hopkins University (2024)</h4>
  <ul class="experience-list">
    <li><strong>Clone‑based WGS</strong> maps sub‑clonal CNVs under Dr.&nbsp;Rajiv&nbsp;McCoy.</li>
    <li><strong>DNA language models</strong> gain speed and accuracy with k‑mer deduplication under Dr.&nbsp;Michael&nbsp;Schatz.</li>
    <li><strong>Retinal organoid atlas</strong> integrates snRNA‑seq to reveal developmental gaps under Dr.&nbsp;Bob&nbsp;Johnston.</li>
    <li><strong>Seq‑to‑function PRS</strong> boosts gene‑trait prediction via fine‑tuned CNNs under Dr.&nbsp;Alexis&nbsp;Battle.</li>
  </ul>

  <!-- Bioinformatician I -->
  <h4 class="experience-title">Research Bioinformatician I — Cedars‑Sinai Medical Center (2022–2024)</h4>
  <ul class="experience-list">
    <li>Led four independent bioinformatics projects on tumor evolution, immunotherapy biomarkers, and spatial proteomics.</li>
    <li>Supervised two junior scientists, collaborated across six labs, and delivered analyses supporting NIH‑funded grants.</li>
    <li>Published high‑impact findings, including a <em>Nature</em> paper on Y‑chromosome loss and immune evasion in bladder cancer.</li>
  </ul>

  <!-- Research Associate & Visiting Grad Student -->
  <h4 class="experience-title">Research Associate I &amp; Visiting Graduate Student — Cedars‑Sinai Medical Center (2021–2022)</h4>
  <ul class="experience-list">
    <li>Integrated RNA‑seq, ATAC‑seq, and single‑cell data to explore tumor microenvironment landscapes.</li>
    <li>Contributed to radiogenomics and multi‑modal cancer staging using AI‑enhanced MRI and RNA‑seq datasets.</li>
    <li>Co‑first author on three peer‑reviewed publications during this period.</li>
  </ul>

  <!-- Early Researcher -->
  <h4 class="experience-title">Early Researcher — Third Xiangya Hospital, Central South University (2020–2021)</h4>
  <ul class="experience-list">
    <li>Conducted immunogenomic analyses on clinical samples from bladder and ovarian cancer patients.</li>
    <li>Initiated development of PyroScore and IMS scoring systems, which became key predictive models in later publications.</li>
  </ul>
</div>


						<!-- Academic CV -->
							<section id="cv">
								<div class="container">
									<header class="major">
										<h2>Academic CV</h2>
									</header
									
									<h4><strong>Previous Roles<strong></h4>
									<ul>
										<li><strong>Research Bioinformatician I<strong>, Cedars-Sinai Medical Center, 2022.8–2024.07</li>
										<li><strong>Research Associate I<strong>, Cedars-Sinai, 2022.04–2022.08</li>
										<li><strong>Visiting Graduate Student<strong>, Cedars-Sinai, 2021.09–2022.03</li>
									</ul>
									
									<h4>Skills</h4>
									<ul>
										<li><strong>Programming:</strong> R, Python, Linux</li>
										<li><strong>Omics:</strong> RNA-seq, ATAC-seq, scRNA-seq, DNA methylation, WGS/WES</li>
										<li><strong>AI/ML:</strong> WGCNA, LASSO, Deep Learning, Random Forest</li>
										<li><strong>Large language model in Genomics:</strong> Pretraining & fine-tuning LLMs · genomic transformer Enformer · Borzoi language model · Decima scheduling RL</li>
										<li><strong>Tools:</strong> CellRanger, Seurat, SCENIC, BioRender, Adobe Illustrator</li>
									</ul>
									
									<h4>Editorial & Peer Review Roles</h4>
									<ul>
										<li><strong>Youth Editor:</strong> iMeta (IF 33.2); Asian Journal of Pharmaceutical Sciences (IF 11.9); Journal of Translational Internal Medicine (IF 7.4) , etc. </li>
										<li><strong>Review Editor:</strong> Frontiers in Urology (IF 1.1), etc.</li>
										<li><strong>Reviewer:</strong> iMeta (IF 33.2), Oncogene (IF 7.3), Frontiers in Immunology (IF 5.9), Seminars in Cancer Biology (IF 12.1), etc.</li>
									</ul>
								</div>
							</section>

						<!-- Contact -->
							<section id="contact">
								<div class="container">
									<header class="major">
										<h2>Contact</h2>
									</header>
									<p>Email: <a href="mailto:xchen295@jh.edu">xchen295@jh.edu</a></p>
									<p>Location: Baltimore, MD</p>
									
									<p>Download my current CV: <a href="https://cheery-sorbet-5f1409.netlify.app/docs/Xingyu_Chen_CV.pdf">PDF Version</a></p>
									
									<ul class="icons">
										<li><a href="https://x.com/Xingyu_Chen_" class="icon brands fa-twitter" target="_blank"><span class="label">Twitter</span></a></li>

										<li><a href="https://scholar.google.com/citations?user=Vj8vClIAAAAJ&hl=en&oi=ao" class="icon solid fa-graduation-cap" target="_blank"><span class="label">Google Scholar</span></a></li>
										<li><a href="https://orcid.org/0000-0002-9284-4950" target="_blank"><img src="images/orcid.png" alt="ORCID" style="width: 24px; height: 24px; vertical-align: middle;"/></a></li>
				
									</ul>
								</div>
							</section>
					</div>

				<!-- Footer -->
					<section id="footer">
						<div class="container">
							<ul class="copyright">
								<li>&copy;2025 Xingyu Chen</li><li>Design: Read Only by ajlkn through <a href="http://html5up.net">HTML5 UP</a></li>
							</ul>
						</div>
					</section>

			</div>

				<!-- Scripts -->
			<script src="assets/js/jquery.min.js"></script>
			<script src="assets/js/jquery.scrollex.min.js"></script>
			<script src="assets/js/jquery.scrolly.min.js"></script>
			<script src="assets/js/browser.min.js"></script>
			<script src="assets/js/breakpoints.min.js"></script>
			<script src="assets/js/util.js"></script>
			<script src="assets/js/main.js"></script>
			<script>
	/* 1. define variables */
	var me = "xchen295";
	var place = "jh.edu";

	/* 2. find email link to replace */
	var elink = document.getElementById("mlink");

	/* 3. replace link href with variables  */
	elink.href = `mailto:${me}@${place}`;
	</script>

	<script src="https://badge.dimensions.ai/badge.js" charset="utf-8"></script>
<script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script>
</body>
</html>
